MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1016/j.acvd.2020.12.010

Медицинская библиотека · Archives of cardiovascular diseases · 2021

Atrial fibrillation increases the risk of recurrent ventricular tachyarrhythmias in implantable cardioverter defibrillator recipients.

Rusnak Jonas, Behnes Michael, Reiser Linda, Schupp Tobias, Bollow Armin, Reichelt Thomas, Borggrefe Martin, Ellguth Dominik, Engelke Niko, El-Battrawy Ibrahim, Ansari Uzair, Barre Max, Weidner Kathrin, Müller Julian, Barth Christian, Meininghaus Dirk Große, Akin Muharrem, Bertsch Thomas, Taton Gabriel, Akin Ibrahim

СтатьяНаблюдательное исследованиеПеревод пока не подготовлен

Аннотация

BACKGROUND

Data regarding recurrences of ventricular tachyarrhythmias in implantable cardioverter defibrillator (ICD) recipients according to atrial fibrillation is limited.

OBJECTIVE

To assess the prognostic impact of atrial fibrillation on recurrences of ventricular tachyarrhythmias in implantable cardioverter defibrillator recipients.

METHODS

A large retrospective registry was used, including all ICD recipients with episodes of ventricular tachycardia or fibrillation from 2002 to 2016. Patients with atrial fibrillation were compared to those without atrial fibrillation. The primary endpoint was first recurrence of ventricular tachyarrhythmias at 5 years. Secondary endpoints comprised recurrences of ICD-related therapies, first cardiac rehospitalization and all-cause mortality at 5 years. Cox regression, Kaplan-Meier and propensity score-matching analyses were applied.

RESULTS

A total of 592 consecutive ICD recipients were included (33% with atrial fibrillation). Atrial fibrillation was associated with reduced freedom from recurrent ventricular tachyarrhythmias (42% vs. 50%, log-rank P=0.004; hazard ratio 1.445, 95% confidence interval 1.124-1.858), mainly attributable to recurrent ventricular fibrillation in secondary-preventive ICD recipients. Accordingly, atrial fibrillation was associated with reduced freedom from first appropriate ICD therapies (31% vs. 42%, log-rank P=0.001; hazard ratio 1.598, 95% confidence interval 1.206-2.118). Notably, the primary endpoint of freedom from first episode of recurrent ventricular tachyarrhythmias was still reduced in those with atrial fibrillation compared to those without atrial fibrillation after propensity score matching. Regarding secondary endpoints, patients with atrial fibrillation still showed a trend towards reduced freedom from appropriate ICD therapies.

CONCLUSIONS

Atrial fibrillation was associated with increased rates of recurrent ventricular tachyarrhythmias and appropriate device therapies in ICD recipients with ventricular tachyarrhythmias.

Для цитирования: Rusnak Jonas, Behnes Michael, Reiser Linda, Schupp Tobias, Bollow Armin, Reichelt Thomas, Borggrefe Martin, Ellguth Dominik, Engelke Niko, El-Battrawy Ibrahim, Ansari Uzair, Barre Max, Weidner Kathrin, Müller Julian, Barth Christian, Meininghaus Dirk Große, Akin Muharrem, Bertsch Thomas, Taton Gabriel, Akin Ibrahim. Atrial fibrillation increases the risk of recurrent ventricular tachyarrhythmias in implantable cardioverter defibrillator recipients.. Archives of cardiovascular diseases. 2021. DOI: 10.1016/j.acvd.2020.12.010.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.